Both our study and existing literature consistently show that large morphometric characteristics (weight, height, BMI), particularly obesity, are associated with a poorer response to anti-TNF treatment (137–139). The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.